US2004242850A1PendingUtilityA1

Antibodies to growth factor homolog zvegf4

Assignee: ZYMOGENETICS INCPriority: May 3, 1999Filed: Jun 25, 2004Published: Dec 2, 2004
Est. expiryMay 3, 2019(expired)· nominal 20-yr term from priority
A61K 38/177A61K 38/1866A61K 38/22C04B 38/06C04B 2111/00612C04B 2111/00224C07K 2319/00A61P 35/00A61K 38/18C12N 2799/022C07K 14/52
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Polypeptide growth factors, methods of making them, polynucleotides encoding them, antibodies to them, and methods of using them are disclosed. The polypeptides comprise an amino acid segment that is at least 70% identical to residues 52-179 of SEQ ID NO:2 or residues 258-370 of SEQ ID NO:2. Multimers of the polypeptides are also disclosed. The polypeptides, multimeric proteins, and polynucleotides can be used in the study and regulation of cell and tissue development, as components of cell culture media, and as diagnostic agents.

Claims

exact text as granted — not AI-modified
We claim:  
     
         1 . An isolated antibody that specifically binds to a protein comprising a first polypeptide disulfide-bonded to a second polypeptide, wherein each of said polypeptides is a polypeptide as shown in SEQ ID NO:2 from amino acid residue X to amino acid residue 370, wherein X is 19, 246, 250, or 258.  
     
     
         2 . The antibody of  claim 1  wherein X is 19.  
     
     
         3 . The antibody of  claim 1  wherein X is 246.  
     
     
         4 . The antibody of  claim 1  wherein X is 250.  
     
     
         5 . The antibody of  claim 1  wherein X is 258.  
     
     
         6 . The antibody of  claim 1  which is a monoclonal antibody.  
     
     
         7 . The antibody of  claim 6  wherein X is 19.  
     
     
         8 . The antibody of  claim 6  wherein X is 246.  
     
     
         9 . The antibody of  claim 6  wherein X is 250.  
     
     
         10 . The antibody of  claim 6  wherein X is 258.  
     
     
         11 . The antibody of  claim 6  which is operably linked to a reporter molecule.  
     
     
         12 . The antibody of  claim 1  which is a single-chain antibody.  
     
     
         13 . The antibody of  claim 1  which is a humanized antibody.  
     
     
         14 . The antibody of  claim 1  which is operably linked to a reporter molecule.

Join the waitlist — get patent alerts

Track US2004242850A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.